Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Parasitol Res ; 119(1): 345-349, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31776667

ABSTRACT

Leishmaniasis is a parasitic disease of medical importance widely distributed around the world. Several methods are available for diagnosis but molecular approaches are highly recommended. To improve the sensitivity of an existing hsp20 gene based-PCR protocol to detect Leishmania parasites, primers were redesigned to amplify a shorter fragment using a new PCR variant (PCR-hsp20S). In this study, we aimed at characterizing the performance of the new method on cutaneous clinical samples and compare it with the former PCR-hsp20. The analytical sensitivity of the PCR-hsp20S was evaluated using DNA dilutions (100-0.1 pg) from Leishmania donovani and resulted in the detection of 10 fg of parasitic DNA, the equivalent to 0.05 parasite genome. For the diagnostic evaluation, a panel of 127 human clinical samples was used to calculate the parameters of sensitivity, specificity, accuracy, and positive and negative predictive values of the PCR-hsp20S. Diagnostic sensitivity was 94% (CI, 89.1-99.7%) and the specificity of 100% (CI, 98.6-100%). The same panel was also evaluated with the PCR-hsp20 to calculate the agreement between both molecular assays and to compare their performances. While both hsp20-based PCRs showed a good agreement coefficient (kappa index = 0.6), the performance of the novel variant, PCR-hsp20S, was significantly higher in terms of sensitivity (P = 0.0001) allowing the accurate detection of a higher number of Leishmania-positive clinical samples. We endorse the use of the PCR-hsp20S over the former protocol for the detection of Leishmania parasites from cutaneous clinical samples. In addition, as an improved sensitivity was achieved with the new method merely through the amplification of a shorter gene fragment, this investigation constitutes an experimental proof of this concept.


Subject(s)
HSP20 Heat-Shock Proteins/genetics , Leishmania donovani/isolation & purification , Leishmaniasis/parasitology , Molecular Diagnostic Techniques/methods , Polymerase Chain Reaction/methods , Animals , DNA Primers/chemistry , DNA, Protozoan/genetics , Humans , Leishmania donovani/genetics , Protozoan Proteins/genetics , Sensitivity and Specificity , Skin/parasitology
3.
Article in English | MEDLINE | ID: mdl-30094054

ABSTRACT

BACKGROUND: Leishmaniasis is a neglected parasitic disease caused by Leishmania spp., which is not endemic in Cuba. However, several factors (such as human activities, climate changes, and tourism) have led to an increase in the number of leishmaniasis cases in all regions, raising diagnosis and surveillance issues. We aim to present the retrospective analysis of 16 human cases suspicious of leishmaniasis, which were received during 2006-2016 for diagnosis at the Department of Parasitology from the Institute of Tropical Medicine Pedro Kourí, Cuba. METHODS: Clinical samples were collected and analyzed via different diagnostic assays, including direct smear, cultivation, histological analysis, and molecular analysis. Epidemiology and background of infection, clinical features, sex and age from each patient was recorded. RESULTS: From the 16 suspicious cases, 5 cases were confirmed for Leishmania infection, based on at least two positive results using different methods: PCR-based diagnosis [18S rRNA (5/5), hsp20 gene (4/5), hsp70 gene (3/5)], histopathology evaluation (2/3), parasite cultivation (2/3), or direct smears (2/3). L. braziliensis and L. mexicana were identified as the involving species in two cases, according to hsp70 PCR-RFLP protocols. Demographic and clinical features, as well as treatment and follow up, are described for every case. CONCLUSIONS: The combination of parasitological and molecular methods allowed proper diagnosis of imported leishmaniasis cases in Cuba. The utility and advantages of molecular diagnosis assays in non-endemic countries like Cuba are discussed.

4.
Parasitol Res ; 116(7): 1843-1848, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28573463

ABSTRACT

Leishmaniasis is highly prevalent in New World countries, where several methods are available for detection and identification of Leishmania spp. Two hsp70-based PCR protocols (PCR-N and PCR-F) and their corresponding restriction fragment length polymorphisms (RFLP) were applied for detection and identification of Leishmania spp. in clinical samples recruited in Colombia, Guatemala, and Honduras. A total of 93 cases were studied. The samples were classified into positive or suspected of leishmaniasis according to parasitological criteria. Molecular amplification of two different hsp70 gene fragments and further RFLP analysis for identification of Leishmania species was done. The detection in parasitologically positive samples was higher using PCR-N than PCR-F. In the total of samples studied, the main species identified were Leishmania panamensis, Leishmania braziliensis, and Leishmania infantum (chagasi). Although RFLP-N was more efficient for the identification, RFLP-F is necessary for discrimination between L. panamensis and Leishmania guyanesis, of great importance in Colombia. Unexpectedly, one sample from this country revealed an RFLP pattern corresponding to Leishmania naiffi. Both molecular variants are applicable for the study of clinical samples originated in Colombia, Honduras, and Guatemala. Choosing the better tool for each setting depends on the species circulating. More studies are needed to confirm the presence of L. naiffi in Colombian territory.


Subject(s)
HSP70 Heat-Shock Proteins/genetics , Leishmania/isolation & purification , Leishmaniasis/parasitology , Polymerase Chain Reaction/veterinary , Animals , Colombia , Guatemala , Honduras , Humans , Leishmania/genetics , Leishmania braziliensis/genetics , Leishmania braziliensis/isolation & purification , Leishmania infantum/genetics , Leishmania infantum/isolation & purification , Leishmaniasis/diagnosis , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Sensitivity and Specificity
5.
Biomedica ; 36(0): 37-44, 2016 Feb 23.
Article in English | MEDLINE | ID: mdl-27622623

ABSTRACT

INTRODUCTION: Leishmaniasis is highly prevalent in Colombia, where at least six different species can cause disease of varying clinical presentations in humans. The identification of the infecting species is quite important for prognosis, therapeutics and epidemiology. Different techniques with variable discriminatory power have been used for the identification.  OBJECTIVE: To carry out the molecular identification of Leishmania species through the amplification of a fragment of the hsp70 gene.  MATERIALS AND METHODS: Molecular amplification of the hsp70 gene fragment (PCR-hsp70) followed by restriction fragment length polymorphism analysis (RFLP) was done for identification purposes using DNA from 81 clinical isolates of Leishmania.  RESULTS: A single amplicon was obtained for all samples analyzed. The enzymatic restrictions of the 81 PCR products identified 70 with a banding pattern corresponding to L. braziliensis with two different patterns (62 and eight isolates, respectively), nine isolates compatible with L. panamensis and two with L. guyanensis. The geographical origin of the isolates is consistent with previous reports about the distribution of the corresponding species in Colombia.  CONCLUSIONS: The PCR-hsp70/RFLP technique used is a valid tool for the identification of Leishmania species isolated from clinical samples of patients in Colombia, which may also be applicable to the study of strains obtained from vectors and reservoirs with epidemiological significance.


Subject(s)
DNA, Protozoan/analysis , HSP70 Heat-Shock Proteins/genetics , Leishmania/chemistry , Polymerase Chain Reaction/methods , Animals , Colombia , DNA, Protozoan/chemistry , HSP70 Heat-Shock Proteins/chemistry , Humans , Leishmaniasis, Cutaneous/genetics , Leishmaniasis, Cutaneous/parasitology , Polymorphism, Restriction Fragment Length
6.
Biomédica (Bogotá) ; 36(supl.1): 37-44, abr. 2016. graf, mapas, tab
Article in Spanish | LILACS | ID: lil-783520

ABSTRACT

Introducción. La leishmaniasis es una enfermedad de gran prevalencia en Colombia, donde al menos seis especies diferentes la originan en el ser humano, con un amplio rango de características clínicas. La tipificación de la especie es importante, no solo desde el punto de vista epidemiológico, sino para el diagnóstico, dado que el tratamiento puede variar dependiendo de la especie identificada. En la identificación se han utilizado varias alternativas metodológicas con diferentes niveles de poder discriminatorio. Objetivo. Identificar especies de Leishmania mediante la amplificación molecular de un fragmento del gen hsp 70. Materiales y métodos. Se amplificó un fragmento del gen hsp 70 mediante reacción en cadena de la polimerasa (PCR- hsp 70) y se hizo el análisis de los polimorfismos de la longitud ( Restriction Fragment Length Polymorphism, RFLP) de los fragmentos de restricción de 81 aislamientos clínicos de Leishmania spp. de pacientes con leishmaniasis cutánea y mucocutánea para la identificación de las especies presentes. Resultados. Se obtuvo un solo amplicón para todas las muestras analizadas. La restricción enzimática de los 81 productos permitió la identificación de 70 con dos patrones de bandas que correspondían a dos alelos de Leishmania braziliensis (62 y ocho aislamientos, respectivamente), nueve aislamientos compatibles con L. panamensis y dos con L. guyanensis . El origen geográfico de los aislamientos coincidió con el de reportes previos sobre la distribución de dichas especies en Colombia. Conclusiones. La técnica de la PCR- hsp 70 y el análisis de RFLP fueron útiles para identificar las especies de Leishmania aisladas de muestras clínicas de Colombia y pueden aplicarse también en el estudio de cepas de vectores y reservorios de importancia epidemiológica.


Introduction: Leishmaniasis is highly prevalent in Colombia, where at least six different species can cause disease of varying clinical presentations in humans. The identification of the infecting species is quite important for prognosis, therapeutics and epidemiology. Different techniques with variable discriminatory power have been used for the identification. Objective: To carry out the molecular identification of Leishmania species through the amplification of a fragment of the hsp 70 gene. Materials and methods: Molecular amplification of the hsp 70 gene fragment (PCR- hsp 70) followed by restriction fragment length polymorphism analysis (RFLP) was done for identification purposes using DNA from 81 clinical isolates of Leishmania . Results: A single amplicon was obtained for all samples analyzed. The enzymatic restrictions of the 81 PCR products identified 70 with a banding pattern corresponding to L. braziliensis with two different patterns (62 and eight isolates, respectively), nine isolates compatible with L. panamensis and two with L. guyanensis . The geographical origin of the isolates is consistent with previous reports about the distribution of the corresponding species in Colombia. Conclusions: The PCR- hsp 70/RFLP technique used is a valid tool for the identification of Leishmania species isolated from clinical samples of patients in Colombia, which may also be applicable to the study of strains obtained from vectors and reservoirs with epidemiological significance.


Subject(s)
Leishmania , Diagnosis , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length
7.
Biomed Res Int ; 2015: 301326, 2015.
Article in English | MEDLINE | ID: mdl-26167482

ABSTRACT

Molecular chaperones are key components in the maintenance of cellular homeostasis and survival, not only during stress but also under optimal growth conditions. Folding of nascent polypeptides is supported by molecular chaperones, which avoid the formation of aggregates by preventing nonspecific interactions and aid, when necessary, the translocation of proteins to their correct intracellular localization. Furthermore, when proteins are damaged, molecular chaperones may also facilitate their refolding or, in the case of irreparable proteins, their removal by the protein degradation machinery of the cell. During their digenetic lifestyle, Leishmania parasites encounter and adapt to harsh environmental conditions, such as nutrient deficiency, hypoxia, oxidative stress, changing pH, and shifts in temperature; all these factors are potential triggers of cellular stress. We summarize here our current knowledge on the main types of molecular chaperones in Leishmania and their functions. Among them, heat shock proteins play important roles in adaptation and survival of this parasite against temperature changes associated with its passage from the poikilothermic insect vector to the warm-blooded vertebrate host. The study of structural features and the function of chaperones in Leishmania biology is providing opportunities (and challenges) for drug discovery and improving of current treatments against leishmaniasis.


Subject(s)
Leishmania/physiology , Molecular Chaperones/physiology , Protozoan Proteins/physiology , Stress, Physiological/physiology , Genome, Protozoan/genetics , Genome, Protozoan/physiology , Heat-Shock Proteins/genetics , Heat-Shock Proteins/physiology , Leishmania/genetics , Molecular Chaperones/genetics , Protozoan Proteins/genetics
8.
Int J Dermatol ; 54(10): 1175-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26095185

ABSTRACT

BACKGROUND: Leishmaniasis represents a polymorphous group of diseases caused by around 20 different species of Leishmania parasite. Increases in the number of cases of leishmaniasis reported as a consequence of the growth in travel and migration are of concern to epidemiologists and are diagnostically challenging in non-endemic areas. METHODS: Molecular and histological analyses of a paraffin-embedded skin biopsy were used in parallel to detect Leishmania parasites in a Cuban woman with suspicious lesions arriving in Cuba from Venezuela. Primers based on the 18S fragment of ribosomal ribonucleic acid (rRNA) and heat shock protein 70 genes (hsp70) were used for molecular detection. RESULTS: Histological studies detected the presence of the parasite. A small fragment of Leishmania DNA was amplified by polymerase chain reaction (PCR) targeting the 18S fragment using, for the first time, nucleic acid obtained from paraffin-embedded tissue as a template. Amplification of a larger fragment from the hsp70 gene did not occur. CONCLUSIONS: The detection of Leishmania DNA from paraffin-embedded tissue by means of 18S-targeted PCR is a feasible approach to diagnosis. In combination with classical methods such as histology, the molecular detection of the parasite was demonstrated to be useful in confirming Leishmania infection in a traveler.


Subject(s)
DNA, Protozoan/analysis , Leishmaniasis, Cutaneous/pathology , Leishmaniasis, Cutaneous/parasitology , RNA, Ribosomal, 18S/genetics , Adult , Cuba , Female , Humans
9.
Rev. peru. med. exp. salud publica ; 31(4): 635-643, oct.-dic. 2014. ilus, tab
Article in Spanish | LILACS, LIPECS, INS-PERU | ID: lil-733243

ABSTRACT

Objetivos. Explorar una nueva diana para el diagnóstico molecular de Leishmania. Materiales y métodos. Se evaluó la utilidad del gen que codifica la proteína de choque térmico de 20kDa (hsp20) para la detección de Leishmania por medio de la reacción en cadena de la polimerasa (PCR).Se normalizó la PCR y se determinaron los parámetros analíticos, así como la validez y seguridad diagnóstica y la concordancia con la PCR-18S. Se evaluó la PCR-hsp20 con ADN obtenido de un grupo de muestras clínicas de distinta procedencia. Resultados. Los parámetros analíticos resultaron adecuados. La sensibilidad obtenida fue de 86% y la especificidad del 100%, la concordancia con el método de referencia resultó buena (ƙ=0,731), lo que apoya su posible uso para el diagnóstico. La posibilidad de identificación posterior de la especie mediante secuenciación del producto amplificado le confiere una ventaja adicional. Conclusiones. Se demuestra la utilidad de este gen como una nueva diana para la detección del género Leishmania. Debido a su potencial, se recomienda mejorar la sensibilidad del procedimiento y realizar su evaluación en diversas regiones endémicas.


Objectives. Explore a new target for molecular diagnosis of Leishmania. Materials and methods. We evaluated the utility of the gene that encodes the heat shock protein 20-kDa (Hsp20) for detecting Leishmania by polymerase chain reaction (PCR). PCR was normalized and analytical parameters were determined, as well as the validity and diagnostic accuracy, and concordance with the PCR - 18S. PCR-Hsp20 with DNA was obtained from a group of clinical samples from different sources. Results. The analytical parameters were adequate. The sensitivity obtained was 86% and the specificity was 100%. The concordance with the reference method was good (Ƙ = 0.731), which supports its potential use for diagnosis. The possibility of subsequent identification of the species by sequencing the amplified product gives an additional advantage. Conclusions. The usefulness of this gene as a new target for the detection of Leishmania was demonstrated. Because of its potential, it is recommended to improve the sensitivity of the method and to evaluate it in different endemic regions.


Subject(s)
Leishmania/genetics , Leishmaniasis/diagnosis
10.
Diagn Microbiol Infect Dis ; 80(1): 35-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25038029

ABSTRACT

In the diagnosis of leishmaniasis, identification of the causative Leishmania species is relevant for treatment, prognosis, and epidemiology. Three new hsp70-based PCR variants were developed and recently validated on clinical samples from Peru, without the need for culturing. We evaluated their performance on 133 clinical samples (bone marrow, blood, buffy coat, lymph node aspirates, lesion biopsies) from 42 cutaneous and 56 visceral leishmaniasis patients and 35 negative cases, all from Old World countries (Italy, Sudan, Israel, and Tunisia). The 3 new PCRs were significantly more sensitive than those previously described for hsp70, and their respective restriction fragment analyses were more efficient for species identification. In 79% of the parasitologically confirmed positive samples, the species could be identified directly from sample DNA. This evaluation demonstrated that these new tools are globally applicable in different geographical, clinical, and sampling contexts, and they could become the reference method for identification of Leishmania species in clinical specimens.


Subject(s)
HSP70 Heat-Shock Proteins/genetics , Leishmania/classification , Leishmania/genetics , Leishmaniasis, Cutaneous/parasitology , Genes, Protozoan/genetics , Humans
11.
Rev Peru Med Exp Salud Publica ; 31(4): 635-43, 2014.
Article in Spanish | MEDLINE | ID: mdl-25597712

ABSTRACT

OBJECTIVES: Explore a new target for molecular diagnosis of Leishmania. MATERIALS AND METHODS: We evaluated the utility of the gene that encodes the heat shock protein 20-kDa (Hsp20) for detecting Leishmania by polymerase chain reaction (PCR). PCR was normalized and analytical parameters were determined, as well as the validity and diagnostic accuracy, and concordance with the PCR - 18S. PCR-Hsp20 with DNA was obtained from a group of clinical samples from different sources. RESULTS: The analytical parameters were adequate. The sensitivity obtained was 86% and the specificity was 100%. The concordance with the reference method was good (κ = 0.731), which supports its potential use for diagnosis. The possibility of subsequent identification of the species by sequencing the amplified product gives an additional advantage. CONCLUSIONS: The usefulness of this gene as a new target for the detection of Leishmania was demonstrated. Because of its potential, it is recommended to improve the sensitivity of the method and to evaluate it in different endemic regions.


Subject(s)
HSP20 Heat-Shock Proteins/genetics , Leishmania/genetics , Leishmania/isolation & purification , Leishmania/classification , Polymerase Chain Reaction , Species Specificity
12.
Diagn Microbiol Infect Dis ; 77(3): 245-7, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24050933

ABSTRACT

Restriction fragment length polymorphisms of the heat-shock protein 70 gene have been used for discriminating Leishmania species. Here, we validated HindII as a much cheaper alternative to EcoRII and SduI for discriminating Leishmania (Viannia) braziliensis from Leishmania (Viannia) naiffi and an atypical Leishmania (V.) braziliensis group, which was previously not possible.


Subject(s)
HSP70 Heat-Shock Proteins/genetics , Leishmania/classification , Leishmania/genetics , Molecular Typing/methods , Parasitology/methods , Polymorphism, Restriction Fragment Length , Protozoan Proteins/genetics , DNA, Protozoan/genetics , DNA, Protozoan/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Polymerase Chain Reaction
13.
Rev. cuba. med. trop ; 64(2): 108-131, mayo-ago. 2012.
Article in Spanish | CUMED | ID: cum-55750

ABSTRACT

Introducción: la leishmaniasis es una enfermedad causada por varias especies del género Leishmania, de la cual se han incrementado los reportes en los últimos años. Diversos factores genéticos, inmunológicos y asociados al parásito determinan el establecimiento de la infección y la ocurrencia de enfermedad, que se presenta en formas clínicas muy diversas, lo cual condiciona, entre otros elementos, el método diagnóstico que se aplica. Métodos: se hizo una revisión de la literatura básica y actualizada sobre aspectos generales de la leishmaniasis: la enfermedad y su situación epidemiológica, el ciclo de vida y la transmisión, vectores, presentaciones clínicas y diagnóstico; este último acápite contiene información sobre los principales métodos que se utilizan en el presente. Se puntualizó en la forma en que se apoya el diagnóstico desde el grupo de Leishmania del Instituto de Medicina Tropical Pedro Kourí, que constituye el centro nacional de referencia para esta enfermedad tropical. Resultados: se muestra información actualizada sobre los temas escogidos, con un enfoque orientador y práctico, dirigido al personal de salud que debe enfrentar casos con sospecha de leishmaniasis. Se muestran tablas y gráficos que resumen de manera organizada aspectos relevantes, así como el algoritmo de trabajo que se sigue en el instituto con relación al diagnóstico de esta enfermedad, con énfasis especial en las aplicaciones al diagnóstico molecular que ha realizado el grupo de trabajo. Conclusiones: debido a que la leishmaniasis permanece aún sin control, el diagnóstico oportuno continúa siendo una necesidad. Todos los métodos aportan información de utilidad para la toma de decisiones en el tratamiento clínico, la imposición del tratamiento y el enfoque epidemiológico de esta parasitosis. Entre ellos, proponemos un algoritmo de trabajo en nuestro laboratorio, con el empleo de los métodos que resultan más útiles de acuerdo a nuestras condiciones y experiencias(AU)


Introduction: leishmaniasis is a disease caused by several species from Leishmania genus, which has been increasingly reported in the last few years. Several genetic, immunological factors and others related to this parasite have been associated to the outcome of the infection, and the occurrence of illness in varied clinical forms. All the aforementioned has an impact on the diagnostic method that should be used. Methods: a basic and recent literature review was made, mainly focused on general aspects of leishmaniasis as epidemiological situation of disease, life cycle and transmission, vectors, clinical presentation and diagnosis; the latter shows information about the main methods used at present. The procedure followed by the Leishmania group at Pedro Kourí Institute of Tropical Medicine to support the diagnostic activities was presented as well. Results: updated practical information about the chosen topics was presented, with a practical guiding approach aimed at the health personnel that must face suspected leishmaniasis cases. Tables and figures summarized relevant aspects in an organized form, as well as the working algorithm of Institute concerning diagnosis was presented. The application of molecular diagnosis by this working team was particularly underlined. Conclusions: as leishmaniasis is still out of control, opportune diagnosis remains a must. All the methods provide useful information for taking decisions on clinical management, treatment and epidemiology of this parasitosis; hence, a working algorithm was submitted in our lab based on the most useful methods under our present conditions and experience(AU)


Subject(s)
Humans , DNA, Protozoan/analysis , Leishmania/genetics , Leishmaniasis/diagnosis , Leishmaniasis/parasitology , Microscopy
14.
Rev. cuba. med. trop ; 64(2): 108-131, Mayo-ago. 2012.
Article in Spanish | LILACS | ID: lil-629370

ABSTRACT

Introducción: la leishmaniasis es una enfermedad causada por varias especies del género Leishmania, de la cual se han incrementado los reportes en los últimos años. Diversos factores genéticos, inmunológicos y asociados al parásito determinan el establecimiento de la infección y la ocurrencia de enfermedad, que se presenta en formas clínicas muy diversas, lo cual condiciona, entre otros elementos, el método diagnóstico que se aplica. Métodos: se hizo una revisión de la literatura básica y actualizada sobre aspectos generales de la leishmaniasis: la enfermedad y su situación epidemiológica, el ciclo de vida y la transmisión, vectores, presentaciones clínicas y diagnóstico; este último acápite contiene información sobre los principales métodos que se utilizan en el presente. Se puntualizó en la forma en que se apoya el diagnóstico desde el grupo de Leishmania del Instituto de Medicina Tropical "Pedro Kourí", que constituye el centro nacional de referencia para esta enfermedad tropical. Resultados: se muestra información actualizada sobre los temas escogidos, con un enfoque orientador y práctico, dirigido al personal de salud que debe enfrentar casos con sospecha de leishmaniasis. Se muestran tablas y gráficos que resumen de manera organizada aspectos relevantes, así como el algoritmo de trabajo que se sigue en el instituto con relación al diagnóstico de esta enfermedad, con énfasis especial en las aplicaciones al diagnóstico molecular que ha realizado el grupo de trabajo. Conclusiones: debido a que la leishmaniasis permanece aún sin control, el diagnóstico oportuno continúa siendo una necesidad. Todos los métodos aportan información de utilidad para la toma de decisiones en el tratamiento clínico, la imposición del tratamiento y el enfoque epidemiológico de esta parasitosis. Entre ellos, proponemos un algoritmo de trabajo en nuestro laboratorio, con el empleo de los métodos que resultan más útiles de acuerdo a nuestras condiciones y experiencias.


Introduction: leishmaniasis is a disease caused by several species from Leishmania genus, which has been increasingly reported in the last few years. Several genetic, immunological factors and others related to this parasite have been associated to the outcome of the infection, and the occurrence of illness in varied clinical forms. All the aforementioned has an impact on the diagnostic method that should be used. Methods: a basic and recent literature review was made, mainly focused on general aspects of leishmaniasis as epidemiological situation of disease, life cycle and transmission, vectors, clinical presentation and diagnosis; the latter shows information about the main methods used at present. The procedure followed by the Leishmania group at "Pedro Kourí" Institute of Tropical Medicine to support the diagnostic activities was presented as well. Results: updated practical information about the chosen topics was presented, with a practical guiding approach aimed at the health personnel that must face suspected leishmaniasis cases. Tables and figures summarized relevant aspects in an organized form, as well as the working algorithm of Institute concerning diagnosis was presented. The application of molecular diagnosis by this working team was particularly underlined. Conclusions: as leishmaniasis is still out of control, opportune diagnosis remains a must. All the methods provide useful information for taking decisions on clinical management, treatment and epidemiology of this parasitosis; hence, a working algorithm was submitted in our lab based on the most useful methods under our present conditions and experience.


Subject(s)
Humans , DNA, Protozoan/analysis , Leishmania/genetics , Leishmaniasis/diagnosis , Leishmaniasis/parasitology , Microscopy
15.
Diagn Microbiol Infect Dis ; 74(2): 142-50, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22819605

ABSTRACT

The heat-shock protein 70 gene (hsp70) has been exploited for Leishmania species identification in the Old and New World, using polymerase chain reaction (PCR) followed by restriction fragment length polymorphism analysis. Three new Leishmania-specific hsp70 PCRs were recently described, and we applied 2 of these on 89 clinical samples from a total of 73 Peruvian patients with either cutaneous or mucocutaneous leishmaniasis. The new PCRs on average showed a 2- to 3-fold improved sensitivity in the tested sample types (lesion biopsies, aspirates, and scrapings), for both genus detection and species typing, and were most successful in biopsies. Leishmania braziliensis, L. peruviana, and L. guyanensis were encountered. About one third of the L. braziliensis parasites contained 2 hsp70 alleles. This study is a paradigm for the implementation of a globally applicable upgraded tool for the identification of Leishmania directly on human specimens from cutaneous and mucocutaneous lesions in the New World.


Subject(s)
Leishmania/classification , Leishmania/genetics , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/parasitology , Polymerase Chain Reaction/methods , Genotype , HSP70 Heat-Shock Proteins/genetics , Humans , Leishmania/isolation & purification , Peru , Protozoan Proteins/genetics
16.
Rev Cubana Med Trop ; 64(2): 108-31, 2012.
Article in Spanish | MEDLINE | ID: mdl-23444631

ABSTRACT

INTRODUCTION: Leishmaniasis is a disease caused by several species from Leishmania genus, which has been increasingly reported in the last few years. Several genetic, immunological factors and others related to this parasite have been associated to the outcome of the infection, and the occurrence of illness in varied clinical forms. All the aforementioned has an impact on the diagnostic method that should be used. METHODS: A basic and recent literature review was made, mainly focused on general aspects of leishmaniasis as epidemiological situation of disease, life cycle and transmission, vectors, clinical presentation and diagnosis; the latter shows information about the main methods used at present. The procedure followed by the Leishmania group at "Pedro Kourí" Institute of Tropical Medicine to support the diagnostic activities was presented as well. RESULTS: Updated practical information about the chosen topics was presented, with a practical guiding approach aimed at the health personnel that must face suspected leishmaniasis cases. Tables and figures summarized relevant aspects in an organized form, as well as the working algorithm of Institute concerning diagnosis was presented. The application of molecular diagnosis by this working team was particularly underlined. CONCLUSIONS: As leishmaniasis is still out of control, opportune diagnosis remains a must. All the methods provide useful information for taking decisions on clinical management, treatment and epidemiology of this parasitosis; hence, a working algorithm was submitted in our lab based on the most useful methods under our present conditions and experience.


Subject(s)
DNA, Protozoan/analysis , Leishmania/genetics , Leishmaniasis/diagnosis , Leishmaniasis/parasitology , Humans , Microscopy
17.
Forsch Komplementmed ; 18(6): 351-3, 2011.
Article in English | MEDLINE | ID: mdl-22189367

ABSTRACT

BACKGROUND: In the present study, an activity of Bixa orellana extract against Leishmania amazonensis was demonstrated. RESULT: Experimentally infected BALB/c mice were treated with B. orellana extract which showed a significant activity against promastigote and amastigote forms of L. amazonensis. CONCLUSION: This study supports the importance of natural sources as antileishmanial drugs.


Subject(s)
Antiprotozoal Agents/pharmacology , Antiprotozoal Agents/therapeutic use , Bixaceae/chemistry , Leishmania/drug effects , Leishmaniasis/drug therapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Amphotericin B/pharmacology , Animals , Body Weight/drug effects , Cell Survival/drug effects , Female , Inhibitory Concentration 50 , Life Cycle Stages/drug effects , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/parasitology , Mice , Mice, Inbred BALB C , Random Allocation
18.
Biomed Pharmacother ; 61(2-3): 148-53, 2007.
Article in English | MEDLINE | ID: mdl-17254746

ABSTRACT

The World Health Organization has classified the leishmaniasis as a major tropical disease. Current therapy is toxic, expensive and cause several adverse effects. The majority of people in endemic areas of leishmaniasis depend of natural and traditional medicine. This study was developed to examine the activity of the essential oil from Chenopodium ambrosioides in BALB/c mice infected with Leishmania amazonensis. The infected animals received two cycle of treatment by different routes (intraperitoneal, oral or intralesional route). The intraperitoneal administration of the essential oil at dose of 30 mg/Kg prevented lesion development and decrease the parasite burden. Oral administration retarded the infection in the experimental model compared with untreated mice, although it was less effective that the intraperitoneal route. The administration by intralesional route did not show activity. Intraperitoneal and oral treatment at 30 mg/Kg with the essential oil had better antileishmanial effect that treatment with the reference drug, amphotericin B at 1 mg/Kg. Preliminarily, we examined the toxicity and the resistance after treatment. Signs of toxicity were evident only in the animals treated by intraperitoneal route. No resistance was detected in L. amazonensis isolates obtained from treated mice. These data clearly demonstrated that this natural product could be an alternative for the development of a new drug against cutaneous leishmaniasis based in the ethnomedical information.


Subject(s)
Antiprotozoal Agents/pharmacology , Chenopodium ambrosioides/chemistry , Leishmania/drug effects , Leishmaniasis, Cutaneous/drug therapy , Oils, Volatile/pharmacology , Administration, Oral , Animals , Antiprotozoal Agents/administration & dosage , Antiprotozoal Agents/adverse effects , Drug Resistance , Female , Injections, Intralesional , Injections, Intraperitoneal , Leishmaniasis, Cutaneous/chemically induced , Mice , Mice, Inbred BALB C , Oils, Volatile/administration & dosage , Oils, Volatile/adverse effects , Parasitic Sensitivity Tests , Plant Oils/chemistry
19.
Chemotherapy ; 52(3): 130-6, 2006.
Article in English | MEDLINE | ID: mdl-16636536

ABSTRACT

BACKGROUND AND METHODS: Current therapy against leishmaniasis is unsatisfactory. Efficacious and safe new drugs are needed. In this study, we show the leishmanicidal effect of an essential oil from Chenopodium ambrosioides against Leishmania amazonensis. RESULTS: The tested product had a potent inhibitory action against promastigote and amastigote forms, with 50% effective dose values of 3.7 and 4.6 microg/ml, respectively. The essential oil showed a moderate toxicity on macrophages from BALB/c mice. An optimal dose of 30 mg/kg/day was effective when administered during 15 days by intraperitoneal route to BALB/c mice infected experimentally. CONCLUSION: These studies revealed a potential source for the discovery of novel drugs to combat the leishmaniasis based on the traditional medicine.


Subject(s)
Chenopodium ambrosioides/chemistry , Leishmania/drug effects , Leishmaniasis, Cutaneous/drug therapy , Oils, Volatile/pharmacology , Plant Oils/pharmacology , Animals , Chenopodium ambrosioides/growth & development , Cuba , Female , Injections, Intraperitoneal , Leishmania/physiology , Leishmaniasis, Cutaneous/parasitology , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Oils, Volatile/administration & dosage , Oils, Volatile/isolation & purification , Plant Oils/administration & dosage , Plant Oils/isolation & purification
20.
Arzneimittelforschung ; 55(4): 232-8, 2005.
Article in English | MEDLINE | ID: mdl-15901047

ABSTRACT

Ten thiadiazine derivatives were tested in vitro for antiparasitic effects against both extracellular promastigotes and intracellular amastigotes of Leishmania amazonensis. The results showed that the evaluated compounds exhibited a strong antiproliferative activity on all developmental stages of the parasite. The minimal inhibitory concentration and the 50 % effective concentration values against the promastigote were 2.1-5.1 microg/ml and 0.6-1.8 microg/ml, respectively. The tested compounds caused an irreversible inhibition of the promastigote growth either after 1 h of treatment with 10 microg/ml or after 24 h with 1 microg/ml. Also, the thiadiazine derivatives were active against amastigotes producing between 12 and 89 % of reduction of infection at 100 ng/ml. However, the compounds exhibited high toxicity and provoked inhibition of the phagocytosis in the murine host cell.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania mexicana/drug effects , Thiadiazines/pharmacology , Animals , Cell Survival/drug effects , Female , Leishmania mexicana/growth & development , Macrophages/drug effects , Macrophages/parasitology , Meglumine/pharmacology , Mice , Mice, Inbred BALB C , Phagocytosis/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...